Literature DB >> 25519800

Tuberculosis and excess alcohol use in the United States, 1997-2012.

T Volkmann1, P K Moonan2, R Miramontes2, J E Oeltmann2.   

Abstract

BACKGROUND: Excess alcohol use among tuberculosis (TB) patients complicates TB control strategies.
OBJECTIVES: To characterize the role of excess alcohol use in TB control, we describe the epidemiology of excess alcohol use and TB in the United States among those aged ⩾15 years.
DESIGN: Using data reported to the National Tuberculosis Surveillance System, 1997-2012, we examined associations between excess alcohol use and TB treatment outcomes and markers for increased transmission (involvement in a local genotype cluster of cases) using multivariate logistic regression. We used Cox proportional hazards regression analysis to examine the relationship between excess alcohol use and the rate of conversion from positive to negative in sputum culture results.
RESULTS: Excess alcohol use was documented for 31 207 (15.1%) of 207 307 patients. Prevalence of excess alcohol use was greater among male patients (20.6%) and US-born patients (24.6%). Excess alcohol use was associated with a positive sputum smear result (aOR 1.23, 95%CI 1.18-1.28) and death during treatment (vs. completion of treatment) (aOR 1.16, 95%CI 1.10-1.22). The rate of culture conversion was higher among patients without excess alcohol use (adjusted hazard ratio 1.20, 95%CI 1.18-1.23).
CONCLUSIONS: Excess alcohol use was common among patients with TB, and was associated with TB transmission, lower rates of sputum culture conversion, and greater mortality.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25519800      PMCID: PMC4798229          DOI: 10.5588/ijtld.14.0516

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  44 in total

1.  Treatment of tuberculosis in HIV-infected patients: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin.

Authors:  S Moreno; D Podzamczer; R Blázquez; J A Iribarren; E Ferrer; J Reparaz; J M Peña; E Cabrero; L Usán
Journal:  AIDS       Date:  2001-06-15       Impact factor: 4.177

2.  American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

Authors:  Henry M Blumberg; William J Burman; Richard E Chaisson; Charles L Daley; Sue C Etkind; Lloyd N Friedman; Paula Fujiwara; Malgosia Grzemska; Philip C Hopewell; Michael D Iseman; Robert M Jasmer; Venkatarama Koppaka; Richard I Menzies; Richard J O'Brien; Randall R Reves; Lee B Reichman; Patricia M Simone; Jeffrey R Starke; Andrew A Vernon
Journal:  Am J Respir Crit Care Med       Date:  2003-02-15       Impact factor: 21.405

3.  Treatment of tuberculosis.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2003-06-20

4.  Adverse effects of antituberculosis drugs.

Authors:  D J Girling
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

5.  Tuberculosis genotyping information management system: enhancing tuberculosis surveillance in the United States.

Authors:  Smita Ghosh; Patrick K Moonan; Lauren Cowan; Juliana Grant; Steve Kammerer; Thomas R Navin
Journal:  Infect Genet Evol       Date:  2011-10-25       Impact factor: 3.342

Review 6.  Pulmonary host defenses and alcohol.

Authors:  Ping Zhang; Gregory J Bagby; Kyle I Happel; Warren R Summer; Steve Nelson
Journal:  Front Biosci       Date:  2002-05-01

7.  Molecular epidemiology of tuberculosis in Slovenia: results of a one-year (2001) nation-wide study.

Authors:  Manca Zolnir-Dovc; Mario Poljak; Damijan Erzen; Jurij Sorli
Journal:  Scand J Infect Dis       Date:  2003

8.  [Impact of social risk factors on treatment outcome in patients with culture positive pulmonary tuberculosis (CPPTB)].

Authors:  Izabela Siemion-Szcześniak; Jan Kuś
Journal:  Pneumonol Alergol Pol       Date:  2012

9.  Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study.

Authors:  Bernard N Muture; Margaret N Keraka; Peter K Kimuu; Ephantus W Kabiru; Victor O Ombeka; Francis Oguya
Journal:  BMC Public Health       Date:  2011-09-09       Impact factor: 3.295

10.  Molecular epidemiology of tuberculosis in a low- to moderate-incidence state: are contact investigations enough?

Authors:  Wendy A Cronin; Jonathan E Golub; Monica J Lathan; Leonard N Mukasa; Nancy Hooper; Jafar H Razeq; Nancy G Baruch; Donna Mulcahy; William H Benjamin; Laurence S Magder; G Thomas Strickland; William R Bishai
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

View more
  18 in total

1.  Over the limit: tuberculosis and excessive alcohol use.

Authors:  C P Chaulk; P K Moonan
Journal:  Int J Tuberc Lung Dis       Date:  2020-01-01       Impact factor: 2.373

2.  The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis.

Authors:  E J Ragan; M B Kleinman; B Sweigart; N Gnatienko; C D Parry; C R Horsburgh; M P LaValley; B Myers; K R Jacobson
Journal:  Int J Tuberc Lung Dis       Date:  2020-01-01       Impact factor: 2.373

3.  Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis.

Authors:  J Morgan Freiman; Karen R Jacobson; Winnie R Muyindike; C Robert Horsburgh; Jerrold J Ellner; Judith A Hahn; Benjamin P Linas
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-01       Impact factor: 3.731

Review 4.  Epidemiology of Tuberculosis in the United States.

Authors:  Adam J Langer; Thomas R Navin; Carla A Winston; Philip LoBue
Journal:  Clin Chest Med       Date:  2019-12       Impact factor: 2.878

5.  Tuberculosis Among Native Hawaiian and Other Pacific Islander Persons: United States and U.S.-Affiliated Pacific Islands, 2010-2019.

Authors:  Molly Deutsch-Feldman; Yuri P Springer; Derrick Felix; Clarisse A Tsang; Richard Brostrom; Maryam Haddad
Journal:  Health Equity       Date:  2022-06-27

6.  Effect of a Nurse-Led Community Health Worker Intervention on Latent Tuberculosis Medication Completion Among Homeless Adults.

Authors:  Adeline Nyamathi; Benissa E Salem; Sanghyuk S Shin; Adrianna A Jones; Dana R Garfin; Kartik Yadav; Alicia H Chang; Kathryn White; Donald Morisky
Journal:  Nurs Res       Date:  2021 Nov-Dec 01       Impact factor: 2.381

7.  Concordance Between Point-of-Care Urine Ethyl Glucuronide Alcohol Tests and Self-Reported Alcohol Use in Persons with HIV in Uganda.

Authors:  Karl C Alcover; Nneka I Emenyonu; Robin Fatch; Allen Kekibiina; Kara Marson; Gabriel Chamie; Winnie R Muyindike; Brian Beesiga; Moses R Kamya; Sara Lodi; Jeremy C Kane; Judith A Hahn; Michael G McDonell
Journal:  AIDS Behav       Date:  2022-02-01

8.  Survival of people living with HIV who defaulted from tuberculosis treatment in a cohort, Recife, Brazil.

Authors:  R Cunha; M Maruza; U R Montarroyos; I Coimbra; D de B Miranda-Filho; M de F Albuquerque; H R Lacerda; Raa Ximenes
Journal:  BMC Infect Dis       Date:  2017-02-10       Impact factor: 3.090

Review 9.  Adolescent tuberculosis.

Authors:  Kathryn J Snow; Andrea T Cruz; James A Seddon; Rashida A Ferrand; Silvia S Chiang; Jennifer A Hughes; Beate Kampmann; Steve M Graham; Peter J Dodd; Rein M Houben; Justin T Denholm; Susan M Sawyer; Katharina Kranzer
Journal:  Lancet Child Adolesc Health       Date:  2019-11-18

10.  Pre-Treatment Neutrophil Count as a Predictor of Antituberculosis Therapy Outcomes: A Multicenter Prospective Cohort Study.

Authors:  Anna Cristina C Carvalho; Gustavo Amorim; Mayla G M Melo; Ana Karla A Silveira; Pedro H L Vargas; Adriana S R Moreira; Michael S Rocha; Alexandra B Souza; María B Arriaga; Mariana Araújo-Pereira; Marina C Figueiredo; Betina Durovni; José R Lapa-E-Silva; Solange Cavalcante; Valeria C Rolla; Timothy R Sterling; Marcelo Cordeiro-Santos; Bruno B Andrade; Elisangela C Silva; Afrânio L Kritski
Journal:  Front Immunol       Date:  2021-07-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.